CAV3 Gene Limbgirdle Muscular Dystrophy Autosomal Dominant Type 1C NGS Genetic DNA Test
Introduction
The CAV3 Gene Limbgirdle Muscular Dystrophy Autosomal Dominant Type 1C NGS Genetic DNA Test is a specialized genetic test that plays a crucial role in diagnosing limb-girdle muscular dystrophy (LGMD). This condition is characterized by progressive muscle weakness and wasting, primarily affecting the muscles around the hips and shoulders. Understanding the genetic basis of this disorder is essential for effective management and treatment.
What the Test Measures
This test specifically detects mutations in the CAV3 gene, which are known to be associated with the autosomal dominant type of limb-girdle muscular dystrophy. By analyzing the genetic material from a blood sample or extracted DNA, the test identifies any abnormalities that may indicate a predisposition to the disorder.
Who Should Consider This Test
Individuals who should consider the CAV3 Gene Limbgirdle Muscular Dystrophy test include:
- Those with a family history of limb-girdle muscular dystrophy.
- Individuals exhibiting symptoms such as muscle weakness, difficulty walking, and muscle wasting.
- Patients referred by a neurologist or genetic counselor for further evaluation.
Benefits of Taking the Test
Taking the CAV3 Gene Limbgirdle Muscular Dystrophy test offers several benefits:
- Accurate diagnosis of genetic conditions.
- Informed family planning and risk assessment for relatives.
- Guidance for personalized treatment and management strategies.
- Access to genetic counseling for emotional and psychological support.
Understanding Your Results
After the test is completed, results will be analyzed and interpreted by genetic specialists. Understanding these results is crucial for making informed decisions regarding health care and management. It is important to discuss the findings with a healthcare provider or genetic counselor to understand the implications and next steps.
Test Details and Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| CAV3 Gene Limbgirdle Muscular Dystrophy Autosomal Dominant Type 1C NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
To schedule your CAV3 Gene Limbgirdle Muscular Dystrophy Autosomal Dominant Type 1C NGS Genetic DNA Test, please contact us at +2348077798758. Early diagnosis can lead to better management and treatment options, so don’t wait! Book your test today and take the first step towards understanding your genetic health.
Turnaround time: 3 to 4 Weeks
Sample type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-test instructions: Clinical History of Patient who is going for CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C.
Specialty: Neurologist | Department: Genetics | Method: NGS Technology | Disease Type: Neurological Disorders
